In this forum, the expert panel discuss changes to the pharmaceutical manufacturing processes during and post the COVID pandemic including what technologies have been adopted to increase speed and efficiencies.
Technology, Innovation & Impact on the Laboratory
REGISTER TO ATTEND THIS ON-DEMAND EDUCATIONAL EVENT
This latest instalment of PHARMA 4.0: Transforming Pharmaceutical Manufacturing is now available on demand. This eConference and Expert Discussion Forums Series features eminent global thought leaders and covers current and future trends in analytical, process, quality and regulatory issues and their impact on the laboratory of the future and its connection to continuous manufacturing.
PHARMA 4.0: Transforming Pharmaceutical Manufacturing brings together participants from industry, academia and regulatory to create an invaluable resource for recent developments, future trends, challenges and solutions for the development & manufacturing of pharmaceutical & biotechnology products.
Impact of COVID on Pharma 4.0
Panellists
Joseph Schariter
Associate Director, Moderna, USA
Hugh Malkin
CEO, CambTEK Ltd, UK
Paul Gamache
Director R&D, Thermo Fisher Scientific, USA
Jared Auclair
Global Biotech Professional, Northeastern University, USA
全てのeConferenceとフォーラムで、日本語字幕をご利用いただけます。
모든 온라인 컨퍼런스 및 포럼에는 한국어 자막이 제공됩니다.
線上論壇及圓桌論壇講師將以英文簡報，並有繁體中文字幕。
